Executive Director, US Access Strategy - Oncology

**Working with Us** Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: https://careers.bms.com/working-with-us. **Summary** The Executive Director of US Market Access Strategy will lead the integrated market access strategy for BMS’s Oncology portfolio (both for inline and pipeline hematology and oncology assets), including oversight of US market access strategy development and execution. Reporting directly to the SVP, Oncology, this highly strategic role will partner closely with his/her Commercial counterpart(s) for the Oncology portfolio to inform access strategy development and oversee its execution. You will partner with senior leaders of Commercial, Medical, and to optimally position BMS products for success in a continuously evolving US market access landscape. You will oversee a team of colleagues who will be accountable for different market access elements including Access Strategy as well understanding how US fits into the global market. This role will need to work with US policy and pricing to determine short- and long-term strategy for the oncology portfolio. This role will be working with business development to get US market access assumptions to determine deal analytics. This role will also be leading oncology strategy for IRA, MFN and other possible policy issues that affect pricing and access of oncology products. A motivated, adaptable, inclusive and decisive disposition is essential for success in this role. A strong candidate should be highly informed on all aspects of market access, have a track record of making complex strategic decisions, leading cross-functional teams, and communicating effectively to senior leaders to reach alignment across the organization. **Responsibilities:** - Develop end-to-end US access strategy for BMS’ full Oncology and hematology in-line and pipeline portfolio - Critical to understand pipeline and be able to transition global launch strategy work quickly to US post CSRE - Need to represent US on the committees for access related decisions eg DEX, CRF, Price exception - Work with and leverage the expertise of their team and functional partners (e.g., l Pricing, PASS, Field Access) to develop strategy for topics like brand pricing, launch sequencing, payer / provider contracting, payer marketing, PASS, and GTN management - Utilize insights from an integrated understanding of MAx, the business, and external trends to develop customized access strategies for various brands / assets under the Oncology business unit - Provide US access strategy support throughout the lifecycle of each asset (i.e., from pre-launch to LOE) - Develop portfolio-wide standard for launch strategy. Establish objectives and metrics for access success. Measure progress towards agreed upon market access and launch objectives. Syndicate with broader leadership team and where appropriate adjust such strategies to meet year end goals - Assess forward-looking trends in the marketplace, working with internal BMS stakeholders to develop innovative approaches to address any external challenges - Build and lead a high performing team by attracting, developing, and retaining individuals through effective coaching and…